According to Edward Dowd's tweet, the FDA plans to phase out certain dyes used in popular snacks like Flamin' Hot Cheetos and Skittles. This regulatory shift could impact market dynamics and investor sentiment surrounding companies reliant on these products. Investors should monitor how companies adapt to these changes as it may affect stock performance.

According to Mark Cuban, NIH research played a role in the approval of every drug by the FDA from 2010 to 2016. This highlights the critical support NIH provides in drug development, which may affect pharmaceutical investment strategies. Traders should consider the importance of NIH-funded research in evaluating pharma stocks.